Back to EZorb Newsletter Index

 

EZorb

  

EZORB MONTHLY NEWSLETTER JUN 28, 2009

 

In this issue:

 

1. Share Success: Letters From Readers
2.

Research News: Long Term Inhaler Use Linked To Pneumonia Risk

3. Useful Links
4. Calcium Absorption Test
5. What Are Others Saying About EZorb?
  

 

1. Share Success: Letters From Readers 

***************************************************

Letter I: From Louise A. W.

Received at sharesuccess @ ezorbonline.com on Tuesday, April 28, 2009 4:10 AM

(Unedited)

 

I was going to wait until I have my next bone scan in six months to send any testimony, but I am feeling so great after taking EZorb for just six months that I have to share the good news.

 

I have severe osteoporosis with three compression fractures in my spine at T6, T9 and T12. In addition, after leaving the USA five months ago to resume my social work in India I had severe pain in my lower back. I went to see my orthopedist and it was discovered on x-ray that my lower spine has scoliosis. I immediately went to see an endocrinologist to see if there was anything else I could do since I am allergic to most allopathic medicine.

 

When I told him I was taking EZorb from the USA he was excited to learn that I am taking Calcium Aspartate Anhydrous. In fact, he said that he and some other physicians are doing their best to bring this product to India. He also gave me some tests to see if I was a good candidate for an annual IV. After the results were back he told me that I can have the IV, but to wait until I do not have any appointments for at least 15 days as I might become sick with flu like symptoms that have been known to last for up to 15 days.

 

That was a month and a half ago and I still have not had the IV as I have started feeling so much better just by taking EZorb, eating a healthy predominantly vegetarian diet and exercising with the OsteoBall. I am no longer taking any pain pills. I am able to ride in the car without pain and I even feel so good I might start doing Yoga again.

 

I will write back again after my next DEXA bone scan.

 

Thanks so much for your product. I am glad I found you on the Internet. Why don't more physicians recommend your product?

 

Louise A. W.

  

   

Letter II: From JoAnn

Received at Testimonial Submit Form on Tuesday, March 03, 2009 at 13:40:32

(Unedited)

    

Hi, my name is JoAnn.

 

Wow, what a transformation!

 

For years I walked 2-3 miles each morning and then last fall all of a sudden I experienced terrible pain in my right heel. I had to give up my walking and just deal with the pain as best I could.

 

Finally I went on line to discover that perhaps it was heel spurs and found this site. I purchased EZorb in early January, this is the beginning of March and I have had no pain or discomfort for the past 2 weeks. I can't say enough good things about this product. I won't be without it. Thank you, thank you, thank you.

  

 

Letter III: From Tim M.

Received at Testimonial Submit Form on Wednesday, January 28, 2009 at 08:01:09

(Unedited)

 

Hi, my name is Tim M. I am on my 3rd bottle of EZorb. I had overall body joint and muscle pain. Since using the product, my pain is barely noticeable. My muscles feel stronger and my energy level has improved. I have tried almost everything and this is by far the superior product.

 

I have just started using the Marvlix and I will let you know the results in about 3 months. I want to thank you so much for such a great product. Thanks again.

 

***************************************************

From the Desk of EZorb Newsletter Editor:

This newsletter is now read by over 50,000 subscribers worldwide. Success stories you contribute will have great impact on many people's life. Kindly email your story to sharesuccess @ ezorbonline.com. As always your private information will never be revealed to the public.

 

 

2. Research News: Long Term Inhaler Use Linked To Pneumonia Risk

 

The long-term use of inhaled corticosteroids, which help to reduce airway inflammation, is associated with an increased risk of pneumonia in people with the lung condition chronic obstructive pulmonary disease, researchers have found.

 

Writing in the Archives of Internal Medicine, Dr Sonal Singh, from Wake Forest University School of Medicine in Winston-Salem, North Carolina, USA, and team explain that inhalers containing corticosteroids are effective for relieving many symptoms of chronic obstructive pulmonary disease.

 

But they add that the results of a number of recent studies have suggested a possible association between the use of inhaled corticosteroids and pneumonia.

 

To investigate further, the researchers reviewed the results of 18 published and unpublished studies involving nearly 17,000 lung disease patients.

 

They compared the incidence of pneumonia among patients who had taken inhaled corticosteroids only, patients who had taken a combination of inhaled corticosteroids and long-acting beta-antagonists, patients who had taken long-acting beta-antagonists only and those who had taken dummy medications.

 

Analysis of the pooled results showed that the use of inhaled corticosteroids alone or in combination with long-acting beta-agonists for at least 24 weeks was associated with a 60-70% increased risk of pneumonia and serious pneumonia.

 

Regarding absolute risk, the researchers calculated that nearly one in every 47 patients with chronic obstructive pulmonary disease who use a corticosteroid inhaler for at least 1 year is likely to develop pneumonia.

 

However, the researchers found that the use of inhaled corticosteroids alone or in combination with long-acting beta-agonists was not associated with an increased risk of death among patients.

 

"Our robust meta-analysis¡­ clarifies that the risk of pneumonia reported as a serious adverse event can be specifically attributed to the long-term use of the inhaled steroid component," the researchers conclude.

 

Dr Singh added: "Given the substantial emerging risk of pneumonia and its associated morbidity [disability due to illness] and mortality in patients with chronic obstructive lung disease, and the uncertain benefit of adding an inhaled corticosteroid to a long-acting bronchodilator, clinicians should re-evaluate the benefit-harm profile of long-term inhaled corticosteroid use among patients with chronic obstructive pulmonary disease."

 

Original research was published in Arch Intern Med 2009; 169: 219-229

 

 

3. Useful Links

Frequently Asked Questions & Answers

EZorb Clinical Studies

Marvlix Benefits

Order Now

  

 

4. Calcium Absorption Test

EZorb Calcium has set a new world record of absorption rate. You can compare EZorb with other calcium supplements by using the simple step-by-step instructions we provide. E-mail your request to test @ ezorbonline.com for a copy of the instructions.

 

 

5. What Are Others Saying About EZorb?

EZorb Calcium has restored confidence in thousands of men and women. It has brought happiness and healthy life to families around the world. Click here to read what people say about EZorb.

   

Back to EZorb Newsletter Index

 
 
  Copyright 2009 Elixir Industry